A Phase 3, double blind, Randomised, Long-Term, Placebo Controlled, Multicentre study Evaluating the safety and efficacy of Obeticholic acid in subjects with Nonalcoholic Steatohepatitis (NASH). (REGENERATE)

1st April 2016 - ongoing

Status: In Recruitment

Specialism: Liver, Non-Alcoholic Fatty Liver Disease (NAFLD).

Team: Professor Guruprasad AithalDr Rob ScottDr Jane ChalmersDr Waleed FateenDr Steve Ryder.

Photo Name Bio
guruprasad-aithal Professor Guruprasad Aithal Professor Aithal has been a Consultant Hepatobiliary Physician at Nottingham University Hospitals NHS trust since 2001. He is the Head of the NIHR Nottingham Digestive Diseases Biomedical Research Centre, and the Head of Division for the Nottingham…
dr-rob-scott Dr Rob Scott
Dr Jane Chalmers
Dr Waleed Fateen
dr-steve-ryder Dr Steve Ryder
Title Amount